Addiction is a disease: We must change our attitudes toward addicts

Stanbrook, Matthew B.

doi:10.1503/cmaj.111957

Cited by 15 publications

(15 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This negative attitude, coupled with the fact that many persons did not think that drug addiction was a mental illness, suggests that in our population drug use is seen as a matter of choice and possibly a moral failing. Such attitudes were widespread in developed countries more than 20 years ago but since that time neuroscientists have in many cases classified addiction as a disease, although this is still somewhat controversial (Volkow & Li, 2004; Stanbrook, 2012). This classification seems to have removed the association of addiction with moral failing but still, as discussed above, it has not eradicated stigmatization.…”

Section: Discussionmentioning

confidence: 99%

Knowledge and attitudes towards mental illness among college students: Insights into the wider English-speaking Caribbean population

Youssef

Bachew

Bodie

et al. 2012

Int J Soc Psychiatry

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Knowledge and attitudes towards mental illness among college students: Insights into the wider English-speaking Caribbean population

Youssef

Bachew

Bodie

et al. 2012

Int J Soc Psychiatry

View full text Add to dashboard Cite

show abstract

“…Nevertheless, addiction is not usually an applicable term to describe the effects of these agents during appropriate treatment of PD with BZs. Furthermore, a commonly exhibited opinion that addiction is a moral failing and that substance use is a choice (Stanbrook, 2012) coupled with a general tendency toward an under-recognition and under-treatment of PD (Bandelow and Michaelis, 2015) might contribute to BZs being deprecated in short-term PD treatment.…”

Section: Selective Serotonin Reuptake Inhibitors and Benzodiazepines mentioning

confidence: 99%

Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment

et al. 2019

View full text Add to dashboard Cite

Background:Benzodiazepines (BZs) and selective serotonin reuptake inhibitors (SSRIs) are effective in the pharmacologic treatment of panic disorder (PD). However, treatment guidelines favor SSRIs over BZs based on the belief that BZs are associated with more adverse effects than SSRIs. This belief, however, is currently supported only by opinion and anecdotes.Aim:The aim of this review and meta-analysis was to determine if there truly is evidence that BZs cause more adverse effects than SSRIs in acute PD treatment.Methods:We systematically searched Web of Science, PubMed, Cochrane Central Register of Controlled Trials, and clinical trials register databases. Short randomized clinical trials of a minimum of four weeks and a maximum of 12 weeks that studied SSRIs or BZs compared to placebo in acute PD treatment were included in a meta-analysis. The primary outcome was all-cause adverse event rate in participants who received SSRIs, BZs, or placebo.Results:Overall, the meta-analysis showed that SSRIs cause more adverse events than BZs in short-term PD treatment. Specifically, SSRI treatment was a risk factor for diaphoresis, fatigue, nausea, diarrhea, and insomnia, whereas BZ treatment was a risk factor for memory problems, constipation, and dry mouth. Both classes of drugs were associated with somnolence. SSRIs were associated with abnormal ejaculation, while BZs were associated with libido reduction. BZs were protective against tachycardia, diaphoresis, fatigue, and insomnia.Conclusion:Randomized, blinded studies comparing SSRIs and BZs for the short-term treatment of PD should be performed. Clinical guidelines based on incontrovertible evidence are needed.

show abstract

“…The Act protects individuals against receiving care they do not want and facilitates the equitable provision of care to marginalized individuals such as IMSH who sometimes face stigmatization when accessing health care ( Habib & Adorjany, 2003 ; Lovi & Barr, 2009 ; Peckover & Chidlaw, 2007 ; Stanbrook, 2012 ). Moreover, informed clients are more likely to actively participate in shared decision making, resulting in better health outcomes and quality of life ( International Council of Nurses, 2003 ; Sackett, Strauss, Richardson, Rosenberg, & Haynes, 2000 ).…”

Section: Legal Requirement For Obtaining Informed Consentmentioning

confidence: 99%

Assessment of Capacity to Consent by Nurses Who Deliver Health Care to Patients Who Misuse Substances

Taylor

Mâsse

et al. 2016

Global Qualitative Nursing Research

View full text Add to dashboard Cite

This qualitative study explored the current practice that nurses use to assess capacity to consent to health care (CTC-HC) in street outreach settings. Key informant interviews were conducted with a purposive sample of nurses from each of British Columbia’s five regional health authorities, allowing nurses to describe their lived experiences with assessing CTC-HC. Content analysis was used to summarize information captured in the data. A total of 19 nurses participated in the study. Five themes emerged from the data: (a) internal guiding forces that contribute to the nurses’ assessment, (b) external influences that contribute to the nurses’ assessment, (c) measures that are important for assessing CTC-HC, (d) threshold setting, and (e) context (physical and interpersonal) within which assessment of capacity takes place. These elements will be incorporated into a capacity assessment tool that can be used in nursing best practices.

show abstract

Addiction is a disease: We must change our attitudes toward addicts

Cited by 15 publications

References 4 publications

Knowledge and attitudes towards mental illness among college students: Insights into the wider English-speaking Caribbean population

Knowledge and attitudes towards mental illness among college students: Insights into the wider English-speaking Caribbean population

Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment

Assessment of Capacity to Consent by Nurses Who Deliver Health Care to Patients Who Misuse Substances

Contact Info

Product

Resources

About